Amicus Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
06.11.25
/
50%
€7.65
Target price
06.11.26
€16.51
Performance (%)
11.11%
Price
05.12.25
€8.40
Summary
This prediction is currently active. The prediction currently has a performance of 11.11%. This prediction currently runs until 06.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | -1.754% | -1.754% |
| iShares Core DAX® | 0.760% | 1.149% |
| iShares Nasdaq 100 | 0.732% | 1.884% |
| iShares Nikkei 225® | 1.025% | -0.865% |
| iShares S&P 500 | -0.036% | 1.480% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $18.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.85
12.11.24
12.11.24
€16.03
12.11.25
12.11.25
-18.27%
13.11.25
13.11.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.40
16.08.24
16.08.24
€14.55
16.08.25
16.08.25
-39.90%
17.08.25
17.08.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.70
29.09.23
29.09.23
€17.92
29.09.24
29.09.24
-19.23%
30.09.24
30.09.24